Summary: A new study suggests that two widely used Type 2 diabetes medicationsGLP-1 receptor agonists and SGLT2 inhibitorsmay help reduce the risk of Alzheimers disease and related dementias. Researc… [+6321 chars]
Ozempic Linked to Lower Alzheimer’s Risk - Neuroscience News
A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.
By:Neuroscience News
Source:Neurosciencenews.com
Published:
Related News
Guest column | I’m a dietitian. Here’s why you shouldn’t label foods as ‘good’ or ‘bad.’ - The Washington Post
There’s a flexible strategy that can help you figure out what to eat based on nutrition, what you enjoy and your health goals, exercise habits and life circumstances.
The Washington Post•Charlotte Carlson | The Conversation
Symptoms explained as outbreak of deadly virus with no cure and 'epidemic potential' reported - LADbible
Cases of the Nipah virus have been confirmed in an Indian hospital
LADbible•Anish Vij
Opinion | Bill Foege’s optimism helped save the world from smallpox - The Washington Post
His design of “surveillance-containment” changed the course of public health strategy.
The Washington Post•Celine Gounder